Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2008-05-15

Clinical Trial Update: Sulfasalazine and Endothelial Function [NA]

View source ↗

Summary

A Boston University study evaluating the effect of sulfasalazine on endothelial function in coronary artery disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sulfasalazine (Sulfasalazine)

Snippet

Sponsor: Boston University | Conditions: Coronary Artery Disease | NA | Status: COMPLETED